Author | Michael E. Williams, MD, ScM | OncLive

Author | Michael E. Williams, MD, ScM

Articles

Dr. Michael Williams on Treating Subtypes of MCL

May 31, 2016

Video

Michael E. Williams, MD, ScM, Byrd S. Leavell Professor of Medicine and Professor of Pathology, University of Virginia Health System, discusses personalized medicine in mantle cell lymphoma (MCL).

Dr. Michael Williams on Lenalidomide Plus Rituximab in First- Line MCL

March 19, 2016

Video

Michael E. Williams, MD, ScM, Byrd S. Leavell Professor of Medicine and Professor of Pathology, University of Virginia Health System, discusses frontline lenalidomide (Revlimid) and rituximab (Rituxan) in mantle cell lymphoma (MCL).

x